University of Oxford — research institution collaborating with Serum Institute of India on Bundibugyo Ebola vaccine development.
Verbatim sentences from the source article.
The Standard
… fi County Hospital between January 1990 and December 2024, drawing on children aged 1 month to 14 years who lived in the rural parts of the county.The study, led by Dr Alice Kamau of the KEMRI-Wellcome Trust Research Programme and Professor Robert Snow of the University of Oxford …
Malaria hospitalisation among children in Kilifi fall to near zero, research reveals.The Standard
… he former an intrinsic value she has nurtured since childhood, to climb up her career ladder, first being appointed as the Head of the Biosciences Department at the KEMRI-Wellcome Trust Research Programme (KWTRP) and Professor of Molecular Epidemiology at the University of Oxford …
Of passion, support, and pacing up the science ladderCitizen Digital
… Benjamin Muriuki September 07, 2026 05:16 (EAT) Add as a Preferred Source on Google Follow us Follow on Whatsapp Follow on Google Follow on Twitter Audio By Vocalize Researchers, policymakers, industry leaders and clean-energy innovators have converged at the University of Oxford …
Global clean energy experts convene at Oxford to advance research partnershipsThe Standard
… This time, researchers moved into clinical testing within weeks.Prof Amanda Rojek, a University of Oxford researcher and international principal investigator of the PARTNERS trial, said: “If we look back at West Africa, where it took us over a year to start clinical trials, we're …
Ebola may have been spreading in DRC weeks before it was detectedCitizen Digital
… The two front-running candidate vaccines are one using the ChAdOx1 platform, being developed by the University of Oxford and the Serum Institute of India, and another being worked on by US pharma firm Moderna using mRNA technology. …
WHO pleads for more support to tackle Ebola outbreakCitizen Digital
… And this past Monday, the first safety trial began on Monday for the ChAdOx1 vaccine, led by the University of Oxford, Tedros said. …
Ebola spreading in DRC 'faster than any previous outbreak': WHOCitizen Digital
… And this past Monday, the first safety trial began on Monday for the ChAdOx1 vaccine, led by the University of Oxford, Tedros said. …
Ebola spreading in DRC 'faster than any previous outbreak': WHOThe Standard
… The first is the PARTNERS trial, coordinated by the World Health Organization (WHO) in collaboration with the DRC's National Institute for Biomedical Research (INRB), the Institute of Tropical Medicine Antwerp, the University of Oxford and Africa CDC. …
Travel restrictions hold as race for Bundibugyo treatments acceleratesThe Standard
… Researchers at the University of Oxford produced the vaccine candidate just 57 days after the World Health Organisation declared the outbreak a Public Health Emergency of International Concern, with hopes it could provide long-term protection if proven safe and effective.Meanwhil …
EBOLA WATCH: Experimental drug trial aims to stop Bundibugyo Ebola after exposureCapital News
… The current trial is sponsored by the WHO, and is being co-ordinated by scientists at the Institut National de Recherche Biomédicale in DRC, the Institute of Tropical Medicine in Belgium, and the University of Oxford in the UK. …
Ebola treatments trial begins in the Democratic Republic of CongoA 35-year study of paediatric malaria admissions at Kilifi County Hospital found that malaria hospitalisations among children aged 1 month to 14 years fell from 25.5 per 1,000 children annually in 1999 to 0.65 per 1,000 children per year by 2020–2024, the longest continuous severe malaria surveillance record in Africa.
15 September 2026 · The Standard →
A 35-year study of paediatric malaria admissions at Kilifi County Hospital found that malaria hospitalisations among children aged 1 month to 14 years fell from 25.5 per 1,000 children annually in 1999 to 0.65 per 1,000 children per year by 2020–2024, the longest continuous severe malaria surveillance record in Africa.
15 September 2026 · The Standard →
Prof Isabella Oyier, Head of the Biosciences Department at the KEMRI-Wellcome Trust Research Programme and Professor of Molecular Epidemiology at the University of Oxford, was appointed Deputy Director (Kilifi) of the KWTRP in May this year. She credits passion and support from mentors as key drivers in her scientific career.
14 September 2026 · The Standard →
Researchers, policymakers and clean-energy innovators gathered at the University of Oxford for the Ayrton-Oxford Academic Symposium, aimed at strengthening international partnerships to accelerate clean-energy research and expand access to affordable and reliable power. The meeting brings together experts from the UK, Africa, Asia and other regions to examine how stronger research collaborations can address energy access, climate change and economic development challenges.
7 September 2026 · Citizen Digital →
A study into the Democratic Republic of Congo's Ebola outbreak, formally declared on May 15, suggests the virus may have already been circulating in communities weeks before recognition. Kenya has raised its Ebola preparedness to nearly 90 per cent, but public-health systems must improve at identifying unusual patterns before they develop into obvious outbreaks.
13 August 2026 · The Standard →
The World Health Organization called for more financial and other resources to combat the Ebola outbreak in the Democratic Republic of Congo, which it described as the biggest ever to have hit the DRC and is still expanding beyond the capacity of response efforts. There have been 3,802 confirmed cases with 1,707 deaths, according to WHO figures.
5 August 2026 · Citizen Digital →
The WHO warned Thursday that Ebola was spreading in the Democratic Republic of Congo more quickly than during any previous outbreak. More than 2,000 cases including 796 deaths have been confirmed since the outbreak was declared two months ago, making it the third-largest Ebola outbreak on record.
17 July 2026 · Citizen Digital →
The World Health Organization warned that Ebola was spreading in the Democratic Republic of Congo more quickly than during any previous outbreak. More than 2,000 confirmed cases including 796 deaths have been reported since the outbreak was declared two months ago, compared to the 2018-2020 outbreak which took more than 10 months to reach 2,000 cases.
17 July 2026 · Citizen Digital →
The US Centers for Disease Control and Prevention and Department of Homeland Security have maintained stringent travel measures, including a Do Not Board list, for people departing the Democratic Republic of the Congo to prevent Bundibugyo Ebola importation during the country's largest recorded outbreak. An American physician infected with the virus while working in the DRC is receiving treatment in Germany.
16 July 2026 · The Standard →
Scientists have launched EBO-PEP, the first clinical trial evaluating post-exposure prophylaxis with an experimental antiviral pill called obeldesivir for Bundibugyo Ebola, among high-risk contacts including family members and healthcare workers in the Democratic Republic of Congo and Uganda. If successful, it would become the first proven strategy to prevent Bundibugyo Ebola after exposure.
15 July 2026 · The Standard →
The WHO has announced the start of a trial testing potential treatments for the Bundibugyo virus strain of Ebola in the Democratic Republic of Congo, with the first patient already enrolled. More than 1,400 cases and 438 deaths have been confirmed in the DRC, and the trial is being coordinated by scientists across institutions in DRC, Belgium, and the UK.
3 July 2026 · Capital News →
An international trial in the Democratic Republic of the Congo has begun enrolling patients to evaluate whether a monoclonal antibody called MBP134 and the antiviral drug remdesivir can improve survival for Bundibugyo virus disease, a rare strain of Ebola for which no approved treatment currently exists.
3 July 2026 · The Standard →
The British government introduced new rules on Tuesday requiring asylum seekers granted refuge in the UK to pay Ksh.1.6 million towards their accommodation if they earn enough, as part of efforts to curb irregular immigration.
1 July 2026 · Citizen Digital →
The United States has provided doses of an experimental antibody drug developed by Mapp Biopharmaceutical to support clinical trials in the Democratic Republic of Congo's Ebola outbreak, marking a shift from prior US-only availability. The move comes as health authorities work to contain a rapidly spreading Bundibugyo strain outbreak that has recorded more than 1,000 cases and over 250 deaths.
24 June 2026 · Capital News →
The U.S. has provided doses of an experimental antibody drug from Mapp Biopharmaceutical for clinical trials in the Democratic Republic of Congo's Bundibugyo Ebola outbreak, which has caused over 1,000 cases and more than 250 deaths. The trial data could inform future U.S. regulatory review and potential approval.
24 June 2026 · Citizen Digital →
The U.S. has provided doses of an experimental antibody drug from Mapp Biopharmaceutical for use in clinical trials and compassionate use to fight an Ebola outbreak in Democratic Republic of Congo. The Bundibugyo strain has caused more than 1,000 cases in Congo and more than 250 deaths, with a handful of cases also reported in Uganda.
24 June 2026 · Citizen Digital →
More than 875 cases of the Bundibugyo Ebola strain have been confirmed, including 202 deaths, in a little over a month across DR Congo and Uganda, with no currently available vaccines or treatments for this strain. Scientists and pharmaceutical companies are racing to develop new vaccines and treatments, with the WHO calling an rVSV-based vaccine candidate "most promising" and estimating it will take seven to nine months before human testing can begin.
18 June 2026 · The Standard →
A Reuters Institute report based on surveys of almost 100,000 people across 48 countries found that 54 percent of respondents got news from social media or video platforms in the week before the survey, exceeding the 52 percent who referenced TV news. This marks the first year social media and video network consumption is ahead of other news sources globally.
16 June 2026 · Citizen Digital →
The Serum Institute of India is leading development of a vaccine targeting the Bundibugyo strain of Ebola in response to an outbreak in the Democratic Republic of Congo first reported in May 2026, which the WHO has declared a Public Health Emergency of International Concern. The vaccine, developed with the University of Oxford and CEPI, uses the same viral vector technology as the Oxford-AstraZeneca COVID-19 vaccine and trial doses are expected in the coming months.
14 June 2026 · Capital News →
Non-profit organisations announced Monday they are ramping up efforts to develop a vaccine for the Bundibugyo strain of Ebola, which has caused an outbreak in the Democratic Republic of Congo and Uganda with nearly 250 suspected deaths and more than 1,100 infections. The strain, for which there are no approved vaccines or treatments, has prompted a race to rapidly develop, manufacture and test a vaccine in clinical trials in the affected region.
1 June 2026 · Citizen Digital →
The 2001 Nobel Prize in Literature award to V.S. Naipaul prompted backlash from the literary community, including Nobel laureate Wole Soyinka, who objected to what they saw as the committee endorsing Naipaul's contemptuous attitude toward his country of origin, Trinidad and Tobago. Naipaul's work portrays broken societies and fractured systems, including depictions of education as uncertain and arbitrary.
16 May 2026 · The Standard →
Monica Juma of Kenya has assumed office in Vienna as Director-General of the UN Office at Vienna and Executive Director of the UN Office on Drugs and Crime (UNODC), following her appointment by UN Secretary-General António Guterres. She previously served as Kenya's first National Security Adviser and held Cabinet Secretary positions in Energy, Defence, and other strategic ministries.
11 May 2026 · Citizen Digital →
Kenyan diplomat Dr. Monica Juma has officially assumed office as Director-General of the United Nations Office at Vienna and Executive Director of the United Nations Office on Drugs and Crime, with the rank of Under-Secretary-General. She expressed commitment to leading the UN's work in addressing drugs, organized crime, corruption, and terrorism.
11 May 2026 · Capital News →